Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simo Decoction for Functional Abdominal Distension
ChiCTR2200056312Phase 4Not yet recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Dec 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Functional abdominal distension (FAD) comparing Placebo control with Simo Decoction (2 arms). Primary endpoints: Hospital Anxiety and Depression Scale score, Overall disease response rate and 3 more. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
simotang
03
Conditions
Functional abdominal distension (FAD)
Beyond the preview
Go deeper on ChiCTR2200056312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056312.